Michele Gaiotto
Managing Principal and Founder @ HTH
Milan, Italy
Michele Gaiotto is a seed investor at HTH in Milan focused on Biotechnology and Health Care. Michele Gaiotto is the Founder and Managing Principal of HTH. He Previously worked at SOM Biotech as a Member of the Board of Directors. Michele Gaiotto attended the University of Padova.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Michele Gaiotto invests in
Stages Michele Gaiotto invests in
Countries Michele Gaiotto invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (100%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Country
- United States 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE). | $10M / Seed / Jun 24, 2024 | ||
| Leuko Labs develops non-invasive white blood cell monitoring device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel,blood draws and laboratory infrastructure. Though its white blood cell monitoring device PointCheck, immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes. | $5M / Series A / Sep 23, 2022 |
Co-Investors
About HTH
HTH is a private Life Science Investment Company. Headquartered in Milan (IT), the company invests worldwide in Biotech, Medtech, Digital Health with a special focus on AI enabled technologies (but not limited to).
HTH Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Michele Gaiotto
Managing Principal and Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Michele Gaiotto invest in?
Michele Gaiotto invests primarily in Biotechnology, Health Care and Medical Device startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Michele Gaiotto?
Public channels for Michele Gaiotto include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michele Gaiotto last invest?
The most recent investment recorded for Michele Gaiotto closed in Jun 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
